The technology is intended to treat distal radius fractures. It has received approval from the U.S. Food and Drug Administration as well as received a CE Mark.
The credit facility is provided by Oxford Finance and Square 1 Bank.
Conventus is a medical device company focused on creating less invasive solutions to treat a broad range of challenging peri-articular fractures.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
